Artesunate-Pyronaridine and Chloroquine to Treat Uncomplicated Plasmodium Vivax Malaria and Prevent Transmission to Mosquitoes: A Phase 2/3, Single Blind, Randomized Clinical Trial in Ethiopia

  1. Migbaru Keffale Bezabih
  2. Solomon Sisay
  3. Sinkinesh Behaksira
  4. Jordache Ramjith
  5. Hiwot Teka
  6. Samuel Girma
  7. Amanuel Shimelash
  8. Legesse Alamerie Ejigu
  9. Fikregabrail Aberra Kassa
  10. Bereket Hailegiorgis
  11. Mekonnen Tadesse
  12. Tadesse Misganaw
  13. Addisu Gizat
  14. Getnet Habtamu Habtamu
  15. Negash Seyoum Legesse
  16. Natnael Lemessa Hundera
  17. Daniel Woldesenbet Milki
  18. Melat Abdo
  19. Wakweya Chali
  20. Jon Eric Tongren
  21. Jimee Hwang
  22. Teun Bousema
  23. Fitsum G. Tadesse

Reviewed by

Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  2. Rapid Reviews Infectious Diseases

    Abebe Fola

    Review 2: "Artesunate-Pyronaridine and Chloroquine to Treat Uncomplicated Plasmodium Vivax Malaria and Prevent Transmission to Mosquitoes: A Phase 2/3, Single Blind, Randomized Clinical Trial in Ethiopia"

    The reviewers agreed this research fills a critical knowledge gap and supports PA+PQ as a promising option for accelerating malaria elimination efforts.

  3. Rapid Reviews Infectious Diseases

    Eric Adehossi

    Review 1: "Artesunate-Pyronaridine and Chloroquine to Treat Uncomplicated Plasmodium Vivax Malaria and Prevent Transmission to Mosquitoes: A Phase 2/3, Single Blind, Randomized Clinical Trial in Ethiopia"

    The reviewers agreed this research fills a critical knowledge gap and supports PA+PQ as a promising option for accelerating malaria elimination efforts.

  4. Version published to 10.2139/ssrn.5259814